Topical Rapamycin to Erase Angiofibromas in TSC

NCT01526356 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

179

Enrollment

OTHER

Sponsor class

Conditions

Angiofibromas
Tuberous Sclerosis

Interventions

DRUG: Placebo
DRUG: Rapamycin
DRUG: Rapamycin

Sponsor

The University of Texas Health Science Center, Houston